Quest Diagnostics (DGX) Tops Q2 EPS by 30c; updates guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts DGX Hot Sheet
Price: $255.68 +3.49%
Financial Fact:
Dividends per common share: 0.4
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Dividends per common share: 0.4
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Quest Diagnostics (NYSE: DGX) reported Q2 EPS of $3.12, $0.30 better than the analyst estimate of $2.82. Revenue for the quarter came in at $3.04 billion versus the consensus estimate of $2.97 billion.
GUIDANCE:
Quest Diagnostics sees FY2026 EPS of $11.05-$11.25, versus the consensus of $10.77. Quest Diagnostics sees FY2026 revenue of $11.95-12.05 billion, versus the consensus of $11.853 billion.
For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CoreCivic (CXW) Misses Q3 EPS by 1530c; raises guidance
- Cognex Corp (CGNX) Tops Q3 EPS by 1c, Misses on Revenue; Offers FY26 Guidance
- Exzeo Group, Inc. (XZO) Reports In-Line Q3 EPS
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
